Robin/openwiki-wiki
1
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity
Files
a9568d86d5c4567db4b9b35241e9b6b89995a66b
openwiki-wiki/sources/web-search.md
T
OpenWiki Bot a9568d86d5 chore: daily update 2026-08-23
2026-08-23 02:33:39 +08:00

107 KiB
Raw Blame History

type, title, description, tags, timestamp
type title description tags timestamp
Reference Web Search Evidence Compact, source-backed evidence and ingestion coverage for the web-search-1 Tavily lane tracking CelVivo, 3Brain, Cellink, and related organoid news.
source
web-search
tavily
celvivo
3brain
cellink
organoids
2026-08-12
2026-08-15
2026-08-16
2026-08-17
2026-08-18
2026-08-19
2026-08-20
2026-08-21
2026-08-22
2026-08-22T18:35:00Z

Web Search Evidence

Connector: web-search-1 (Tavily). This page records compact, relevant evidence from Tavily pulls; search results are discovery leads, not vendor-confirmed announcements. Latest successful pull: 2026-08-03 18:08 UTC. The 2026-08-08, 2026-08-10, 2026-08-12, 2026-08-15, 2026-08-17, 2026-08-18, 2026-08-19, 2026-08-20, 2026-08-21, and 2026-08-22 update attempts were skipped because the connector is disabled and TAVILY_API_KEY is not present; no new 24-hour evidence was available on any of these ten runs.

2026-08-22 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. The nightly searxng-fallback slot (~/.openwiki/connectors/web-search/raw/2026-08-21T18-35-04-searxng-fallback/) is also empty (confirmed empty on disk) — no web-search evidence of any kind landed in the 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.
  • Operational note (cross-check): the on-disk ~/.openwiki/connectors/web-search/config.json does show enabled: true plus 6 Chinese-language queries (CelVivo ClinoStar ClinoReactor 类器官培养新进展, 3Brain HD-MEA 高密度微电极阵列 电生理, Cellink BIO X 3D生物打印 类器官, Femtobiomed CellShot 流式电转 精准医疗, 类器官 vendor 2026年新发布, MiniMax M3 智能体 Hermes). The agent runtime still reports the connector as disabled, so there is a discrepancy between disk config and runtime registry. This is an operational concern (connector enable / auth / re-registration), not a wiki-synthesis concern, and is recorded here for traceability rather than triggering wiki edits. The 2026-08-08, 2026-08-10, 2026-08-12, 2026-08-15, 2026-08-17, 2026-08-18, 2026-08-19, 2026-08-20, and 2026-08-21 runs hit the same blocker; this is the tenth consecutive skip on the same code path. To resolve: set TAVILY_API_KEY in the OpenWiki runtime environment and ensure the runtime registry refreshes the connector's enabled state.

2026-08-21 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. The nightly searxng-fallback slot (~/.openwiki/connectors/web-search/raw/2026-08-20T18-35-03-searxng-fallback/) is also empty (confirmed empty on disk) — no web-search evidence of any kind landed in the 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.
  • Operational note (cross-check): the on-disk ~/.openwiki/connectors/web-search/config.json does show enabled: true plus 6 Chinese-language queries (CelVivo ClinoStar ClinoReactor 类器官培养新进展, 3Brain HD-MEA 高密度微电极阵列 电生理, Cellink BIO X 3D生物打印 类器官, Femtobiomed CellShot 流式电转 精准医疗, 类器官 vendor 2026年新发布, MiniMax M3 智能体 Hermes). The agent runtime still reports the connector as disabled, so there is a discrepancy between disk config and runtime registry. This is an operational concern (connector enable / auth / re-registration), not a wiki-synthesis concern, and is recorded here for traceability rather than triggering wiki edits. The 2026-08-08, 2026-08-10, 2026-08-12, 2026-08-15, 2026-08-17, 2026-08-18, 2026-08-19, and 2026-08-20 runs hit the same blocker; the 2026-08-22 run hit the same blocker too. This was the ninth consecutive skip on the same code path at the time of the 2026-08-21 attempt (and the tenth skip including the 2026-08-22 follow-up). To resolve: set TAVILY_API_KEY in the OpenWiki runtime environment and ensure the runtime registry refreshes the connector's enabled state.

2026-08-20 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. The nightly searxng-fallback slot (~/.openwiki/connectors/web-search/raw/2026-08-19T18-35-03-searxng-fallback/) is also empty — no web-search evidence of any kind landed in the 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.
  • Operational note (cross-check): the on-disk ~/.openwiki/connectors/web-search/config.json does show enabled: true plus 6 Chinese-language queries (CelVivo ClinoStar ClinoReactor 类器官培养新进展, 3Brain HD-MEA 高密度微电极阵列 电生理, Cellink BIO X 3D生物打印 类器官, Femtobiomed CellShot 流式电转 精准医疗, 类器官 vendor 2026年新发布, MiniMax M3 智能体 Hermes). The agent runtime still reports the connector as disabled, so there is a discrepancy between disk config and runtime registry. This is an operational concern (connector enable / auth / re-registration), not a wiki-synthesis concern, and is recorded here for traceability rather than triggering wiki edits. The 2026-08-08, 2026-08-10, 2026-08-12, 2026-08-15, 2026-08-17, 2026-08-18, and 2026-08-19 runs hit the same blocker; the 2026-08-21 + 2026-08-22 runs hit the same blocker too. This was the eighth consecutive skip on the same code path at the time of the 2026-08-20 attempt (and the tenth skip including the 2026-08-21 + 2026-08-22 follow-ups). To resolve: set TAVILY_API_KEY in the OpenWiki runtime environment and ensure the runtime registry refreshes the connector's enabled state.

2026-08-19 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. The nightly searxng-fallback slot (~/.openwiki/connectors/web-search/raw/2026-08-18T18-35-03-searxng-fallback/) is also empty — no web-search evidence of any kind landed in the 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.
  • Operational note (cross-check): the on-disk ~/.openwiki/connectors/web-search/config.json does show enabled: true plus 6 Chinese-language queries (CelVivo ClinoStar ClinoReactor 类器官培养新进展, 3Brain HD-MEA 高密度微电极阵列 电生理, Cellink BIO X 3D生物打印 类器官, Femtobiomed CellShot 流式电转 精准医疗, 类器官 vendor 2026年新发布, MiniMax M3 智能体 Hermes). The agent runtime still reports the connector as disabled, so there is a discrepancy between disk config and runtime registry. This is an operational concern (connector enable / auth / re-registration), not a wiki-synthesis concern, and is recorded here for traceability rather than triggering wiki edits. The 2026-08-08, 2026-08-10, 2026-08-12, 2026-08-15, 2026-08-17, and 2026-08-18 runs hit the same blocker; the 2026-08-20, 2026-08-21, and 2026-08-22 runs hit the same blocker too. This was the seventh consecutive skip on the same code path at the time of the 2026-08-19 attempt (and the tenth skip including the 2026-08-20, 2026-08-21, and 2026-08-22 follow-ups). To resolve: set TAVILY_API_KEY in the OpenWiki runtime environment and ensure the runtime registry refreshes the connector's enabled state.

2026-08-18 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. The nightly searxng-fallback slot (~/.openwiki/connectors/web-search/raw/2026-08-17T18-35-03-searxng-fallback/) is also empty — no web-search evidence of any kind landed in the 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.
  • Operational note (cross-check): the on-disk ~/.openwiki/connectors/web-search/config.json does show enabled: true plus 6 Chinese-language queries (CelVivo ClinoStar ClinoReactor 类器官培养新进展, 3Brain HD-MEA 高密度微电极阵列 电生理, Cellink BIO X 3D生物打印 类器官, Femtobiomed CellShot 流式电转 精准医疗, 类器官 vendor 2026年新发布, MiniMax M3 智能体 Hermes). The agent runtime still reports the connector as disabled, so there is a discrepancy between disk config and runtime registry. This is an operational concern (connector enable / auth / re-registration), not a wiki-synthesis concern, and is recorded here for traceability rather than triggering wiki edits. The 2026-08-08, 2026-08-10, 2026-08-12, 2026-08-15, and 2026-08-17 runs hit the same blocker; the 2026-08-19, 2026-08-20, 2026-08-21, and 2026-08-22 runs hit the same blocker too. This was the sixth consecutive skip on the same code path at the time of the 2026-08-18 attempt (and the tenth skip including the 2026-08-19, 2026-08-20, 2026-08-21, and 2026-08-22 follow-ups).

2026-08-17 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. The nightly searxng-fallback slot (~/.openwiki/connectors/web-search/raw/2026-08-16T18-35-03-searxng-fallback/) is also empty — no web-search evidence of any kind landed in the 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.
  • Operational note (cross-check): the on-disk ~/.openwiki/connectors/web-search/config.json does show enabled: true plus 6 Chinese-language queries (CelVivo ClinoStar ClinoReactor 类器官培养新进展, 3Brain HD-MEA 高密度微电极阵列 电生理, Cellink BIO X 3D生物打印 类器官, Femtobiomed CellShot 流式电转 精准医疗, 类器官 vendor 2026年新发布, MiniMax M3 智能体 Hermes). The agent runtime still reports the connector as disabled, so there is a discrepancy between disk config and runtime registry. This is an operational concern (connector enable / auth / re-registration), not a wiki-synthesis concern, and is recorded here for traceability rather than triggering wiki edits. The 2026-08-08, 2026-08-10, 2026-08-12, and 2026-08-15 runs hit the same blocker; the 2026-08-18, 2026-08-19, 2026-08-20, 2026-08-21, and 2026-08-22 runs hit the same blocker too. This was the fifth consecutive skip on the same code path at the time of the 2026-08-17 attempt (and the tenth skip including the 2026-08-18, 2026-08-19, 2026-08-20, 2026-08-21, and 2026-08-22 follow-ups).

2026-08-15 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.
  • Operational note (cross-check): the on-disk ~/.openwiki/connectors/web-search/config.json does show enabled: true plus 6 Chinese-language queries (CelVivo ClinoStar ClinoReactor 类器官培养新进展, 3Brain HD-MEA 高密度微电极阵列 电生理, Cellink BIO X 3D生物打印 类器官, Femtobiomed CellShot 流式电转 精准医疗, 类器官 vendor 2026年新发布, MiniMax M3 智能体 Hermes). The agent runtime still reports the connector as disabled, so there is a discrepancy between disk config and runtime registry. This is an operational concern (connector enable / auth / re-registration), not a wiki-synthesis concern, and is recorded here for traceability rather than triggering wiki edits. The 2026-08-08, 2026-08-10, and 2026-08-12 runs hit the same blocker; the 2026-08-17, 2026-08-18, 2026-08-19, 2026-08-20, 2026-08-21, and 2026-08-22 runs hit the same blocker too. This was the fourth consecutive skip on the same code path at the time of the 2026-08-15 attempt (and the tenth skip including the 2026-08-17, 2026-08-18, 2026-08-19, 2026-08-20, 2026-08-21, and 2026-08-22 follow-ups).

2026-08-12 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.
  • Operational note (cross-check): the on-disk ~/.openwiki/connectors/web-search/config.json does show enabled: true plus 6 Chinese-language queries (CelVivo ClinoStar ClinoReactor 类器官培养新进展, 3Brain HD-MEA 高密度微电极阵列 电生理, Cellink BIO X 3D生物打印 类器官, Femtobiomed CellShot 流式电转 精准医疗, 类器官 vendor 2026年新发布, MiniMax M3 智能体 Hermes). The agent runtime still reports the connector as disabled, so there is a discrepancy between disk config and runtime registry. This is an operational concern (connector enable / auth / re-registration), not a wiki-synthesis concern, and is recorded here for traceability rather than triggering wiki edits. The 2026-08-08 and 2026-08-10 runs hit the same blocker; this is the third consecutive skip on the same code path.

2026-08-10 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.
  • Operational note (cross-check): the on-disk ~/.openwiki/connectors/web-search/config.json does show enabled: true plus 6 Chinese-language queries (CelVivo ClinoStar ClinoReactor 类器官培养新进展, 3Brain HD-MEA 高密度微电极阵列 电生理, Cellink BIO X 3D生物打印 类器官, Femtobiomed CellShot 流式电转 精准医疗, 类器官 vendor 2026年新发布, MiniMax M3 智能体 Hermes). The agent runtime still reports the connector as disabled, so there is a discrepancy between disk config and runtime registry. This is an operational concern (connector enable / auth / re-registration), not a wiki-synthesis concern, and is recorded here for traceability rather than triggering wiki edits.

2026-08-08 attempted update — skipped

  • Status: skipped. web-search-1 is not enabled; the connector reports that enabled=true must be set in ~/.openwiki/connectors/web-search/config.json.
  • Authentication: TAVILY_API_KEY is not present, so no Tavily request was made.
  • Coverage: no raw data files were written for this attempted 24-hour window. No new CelVivo, 3Brain, Cellink, or organoid findings were available for synthesis; the latest successful pull remains 2026-08-03 18:08 UTC.
  • Synthesis: no changes were made to /themes.md, /commitments.md, /open-questions.md, or /personal-logistics.md from this source attempt.

Historical successful pulls

The detailed pull records below preserve the prior evidence trail in chronological order.

3D spheroid automation and assay standardization — source-backed

  • Nature, published 2026-07-21: Automation of 3D liver spheroid generation and acetaminophen dose–response on the MO:BOT enhances assay robustness and precision. The article describes an integrated automated workflow for generating and maintaining 3D liver spheroids and links standardization, reproducibility, and consistent morphology/function to broader adoption of 3D human-cell models in preclinical research.
  • Robin relevance: strong application signal for CelVivo-style spheroid workflows and pharma assay discussions, but the result is about MO:BOT rather than CelVivo. Treat as a competitive/application watchlist lead, not a CelVivo product claim.
  • Related result: the same Nature article appeared in the Cellink BIO X and CellShot/CellPick searches; the snippets characterize 3D bioprinters as useful for complex ECM-embedded constructs but generally narrower than an end-to-end maintenance/readout workflow.

Organ-on-chip and preclinical translation — watchlist

3Brain / neuroscience search lane — no direct product confirmation

  • The strongest result was a 2026-07-24 Scientific Reports article on a portable semi-dry EEG device for brain-computer-interface applications (Nature link); it does not identify 3Brain CorePlate or MEA chips. Do not promote it as 3Brain evidence.

Cellink, Femtobiomed, and workflow tooling

  • The pull produced no credible direct Cellink BIO X/BIONOVA X/Lumen X announcement, no CellShot/CellPick/TriArm result, and no Hermes/OpenWiki/RAGFlow ecosystem result.
  • The CellShot search returned a Cellares/Papillon automation partnership, but this is unrelated to Femtobiomed's CellShot product and is excluded from synthesis.

Evidence handling

  • Search results are single-source discovery evidence; vendor-specific claims require direct vendor or independent corroboration before being labeled confirmed or source-backed.
  • Generic bioprinting, cell-therapy manufacturing, unrelated EEG, and off-topic AI results from this pull were discarded as noise under Robin's scope.

Source coverage

  • Fetched: 2026-07-26T17:39:11Z
  • Queries: 10
  • Instance: web-search-1
  • Raw evidence: ~/.openwiki/connectors/web-search/raw/2026-07-26T17-38-33-286Z/web-search-results.json

2026-07-26 18:07 pull

Second Tavily pull on the same day (same 10-query lane). Three lanes produced material new evidence (China regulatory, organ-on-chip/CDMO, Hermes agent model eval). CelVivo / 3Brain / Cellink lanes re-surfaced the earlier Nature papers with Tavily's answer text mis-attributing vendor names — flagged below.

China CDE cell & gene therapy classification — source-backed

Organ-on-chip / CDMO collaboration / ADLM 2026 — source-backed

Hermes Agent best-models eval — source-backed (workflow tooling, low priority)

  • haimaker.ai, 2026-07-23: Best Models for Hermes Agent (July 2026): Tested & Ranked. 0.731 score. Third-party ranking of LLMs for Hermes Agent usage — Robin-relevant as the daily-driver stack. Folds into the existing MiniMax-m3 theme row last-seen.
  • Reddit, 2026-07-22: What are you USE CASES for Hermes Agent?. 0.424 score. User-driven Hermes use cases; not a vendor-anchored signal.
  • Data-quality flag: Tavily's synthesized answer for this lane hallucinated detail ("streaming robustness, REPL UX improvements, and provider hardening") — none of those bullets appear in the haimaker article. Treat Tavily's answer text as untrusted.

CelVivo / 3Brain / Cellink / CellShot lanes — same Nature results, Tavily answer text mis-attributed

  • CelVivo ClinoReactor / Cellink BIO X: the Nature MO:BOT liver-spheroid automation paper reappears at score 0.402 (CelVivo lane) and 0.074 (Cellink lane). Tavily's answer text describes MO:BOT but labels the platform "ClinoReactor" / "BIO X" — vendor attribution is wrong. Treat the result as the MO:BOT paper, not a CelVivo or Cellink product claim.
  • 3Brain CorePlate MEA: the Nature portable semi-dry EEG device paper reappears at score 0.187. Tavily's answer text labels it "3Brain CorePlate MEA 2026" — this is wrong; the paper is about an EEG headset, not 3Brain's MEA chips. Do not promote as 3Brain evidence.
  • CellShot / CellPick: Cellares–Papillon partnership (Cellares is unrelated to Femtobiomed) and CCDx liquid biopsy — no direct Femtobiomed result in either pull.
  • CelVivo installed-base: no direct result; pull dominated by Cepheid GeneXpert noise. Query phrasing needs a vendor-name anchor to retrieve CelVivo-specific results.

OpenWiki / RAGFlow / agent-memory-wiki lanes — Tavily recall broken

  • "OpenWiki connectors Tavily RAGFlow 2026" returned SmartBall X pipeline inspection, AWWA ACE26, insurance backchat, helicopter partnership, OLED manufacturing equipment, and fashion-show slides. None of the 8 results touches Robin's actual stack (OpenWiki / Gitea / Wiki.js / RAGFlow / NocoDB / SeaFile). Skip until the query is rephrased.
  • "Agent personal memory wiki 2026" returned an Australian enterprise data-AI survey (0.403), a LangChain4j self-building-agent experiment (0.168), and ad-agency awards — no direct personal-wiki / OpenWiki-self evidence. Adjacent only.

Source coverage (cumulative)

  • Pull 1: fetched 2026-07-26T17:39:11Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T17-38-33-286Z/web-search-results.json
  • Pull 2: fetched 2026-07-26T18:07:27Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T18-07-14-335Z/web-search-results.json
  • Pull 3: fetched 2026-07-26T18:16:21Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T18-16-06-804Z/web-search-results.json
  • Queries: pull 1 + pull 2 = 10 queries each; pull 3 = 6 queries (vendor-anchored only)
  • Instance: web-search-1

2026-07-26 18:16 pull

Third Tavily pull on the same day, after the 2026-07-27 ~/.openwiki/INSTRUCTIONS.md scope was loaded. The query lane was narrowed from 10 vendor-mixed queries to 6 vendor-anchored queries, dropping the China-cell-therapy regulation lane (now stale-pinned via /commitments.md), the Hermes Agent / MiniMax M3 daily-driver lane, and the OpenWiki/RAGFlow/agent-memory lanes (the latter two were already noise per the prior pulls).

Queries and top results

Query Top hits Score Vendor-anchor
CelVivo ClinoReactor spheroid new paper 2026 Nature MO:BOT liver-spheroid automation paper (re-mention); Patient-Derived Tumor Organoids for personalizing cancer treatment; CCDx whole-cell genomic profiling 0.44 / 0.11 / 0.05 no — MO:BOT, not CelVivo; organoid application only
3Brain CorePlate MEA neuron 2026 News-Medical.net "New imaging platform tracks hundreds of neurons at unprecedented depths"; BioSpace brain-remodeling-during-adolescence; MobiHealthNews first able-bodied BCI recipients 0.20 / 0.10 / 0.08 no — generic neuroscience imaging, not 3Brain CorePlate
Cellink BIO X bioprinter clinical 2026 Roche ADLM 2026 intelligent lab solutions; 10x Genomics CLIA lab + Cleveland Clinic; Massive Bio FOMAT cancer prescreening 0.11 / 0.09 / 0.07 no — industry context; 10x / Massive Bio unrelated to Cellink
organoid-on-chip pharmacology 2026 AcroCyte Therapeutics ARPA-H funding for scalable human-organoid tech (re-mention, score up to 0.617 from 0.215); Patient-Derived Tumor Organoids; Nature MO:BOT liver-spheroid 0.62 / 0.41 / 0.35 no — AcroCyte is application, not one of Robin's 4 vendors
CellShot CellPick bioprinter research 2026 Cellares–Papillon PPL-001 automation partnership (re-mention); CCDx whole-cell genomic profiling; Genetic Engineering AI protein-engineering for biomanufacturing 0.17 / 0.14 / 0.08 no — Cellares/Papillon unrelated to Femtobiomed
lab automation assay workflow news 2026 Roche ADLM 2026; Nature MO:BOT liver-spheroid; Cepheid third-generation GeneXpert at ADLM 2026 0.82 / 0.74 / 0.56 no — Roche/Cepheid industry context, not vendor-anchored

Synthesis result

  • No new vendor-anchored evidence — every query's top hit is either (a) application/organoid-level without naming Robin's 4 vendors, (b) a re-mention of an item already in the 17:38 or 18:07 pull, or (c) an unrelated industry/competitor brand (Roche, Cepheid, 10x, Cellares, Massive Bio, CCDx).
  • AcroCyte ARPA-H reappears at 0.617 (up from 0.215 in the 18:07 pull). Same item, stronger score — the existing /themes.md class-organoid-3d-bioprinting row already covers it via the ARPA-H funding evidence; no new row needed.
  • Tavily answer-text vendor mis-attribution continues. The CelVivo ClinoReactor spheroid new paper 2026 answer text describes MO:BOT but labels it "ClinoReactor"; the 3Brain CorePlate MEA neuron 2026 answer text points at generic brain-imaging news without anchoring to CorePlate. Treat Tavily answer text as untrusted and only the underlying URLs as evidence.
  • Dropped lanes (vs. pull 2): China cell therapy 3D bioprinting regulation 2026 (China CDE item still anchored in /commitments.md as china-cde-cell-gene-therapy-rules-2026); Hermes Agent MiniMax M3 changelog 2026 (already in /themes.md MiniMax-m3 row); OpenWiki connectors Tavily RAGFlow 2026 (noise); agent personal memory wiki 2026 (noise). Existing rows on /themes.md and /commitments.md are unchanged because their evidence sources (Tavily pull 2, HN pull 18:00) are still on disk and referenceable.

Coverage note for next update

The China CDE regulatory lane is no longer being refreshed on every Tavily pull. The existing /commitments.md item pins it as source-backed with one credible cisema.com source. If a future Tavily or HN pull surfaces an NMPA / CDE-direct corroboration, promote from watchlist to source-backed and move into /themes.md as a confirmed row.

2026-07-27 18:04 pull

Fourth Tavily pull on the 2026-07-27 cycle, run as a stand-alone openwiki personal --update source ingest. All 10 queries were re-run. Two lanes produced genuinely new material evidence (CelVivo / ClinoReactor vendor-anchored signal; Hermes Agent v0.19 Quicksilver workflow-tooling release). One lane (3D-bioprinted-organoid reviews) added supporting evidence to the existing class-organoid-3d-bioprinting row. The Tavily answer-text mis-attribution pattern recurred on the 3Brain, Cellink, and MiniMax-M3 lanes — flagged again below.

CelVivo ClinoReactor + TheWell Bioscience xeno-free workflow — source-backed

This is the first vendor-anchored CelVivo signal in any Tavily pull. Prior pulls returned only MO:BOT or generic organoid content. Three TheWell Bioscience pages published in the 2026-07-21 / 2026-07-23 / 2026-07-25 window all reference "CelVivo ClinoReactor™" by name in their product content:

Tavily answer-text quality is honest on this lane — the response correctly names TheWell Bioscience's xeno-free product and references ClinoReactor, not hallucinated vendor attributions.

Robin relevance: high. This is the only Tavily pull where CelVivo ClinoReactor has been named by a vendor-adjacent (media/reagent) partner, with three same-week pages and a white paper. Possible interpretations: (a) CelVivo-TheWell co-marketing agreement; (b) TheWell is using ClinoReactor as a reference platform for their own product positioning; (c) organic partner content. Promoted to /commitments.md as celvivo-clinoreactor-thewell-bioscience-xeno-free with status "verify on next CelVivo vendor check". The new evidence is also folded into the class-organoid-3d-bioprinting row.

Hermes Agent v0.19 "Quicksilver" Release — source-backed (workflow tooling, low priority)

The Hermes Agent MiniMax M3 changelog 2026 query returned a material release note for Hermes Agent v0.19, the "Quicksilver" release from Nous Research. Note: Tavily's answer text hallucinated attribution to "MiniMax M3" (the underlying subject is Hermes Agent, not the M3 model). The underlying URLs confirm the release:

Robin relevance: Hermes Agent is Robin's daily-driver stack per ~/.openwiki/INSTRUCTIONS.md. v0.19's profile routing, live subagent, and 1Password/Bitwarden integration are story-worthy shifts. New theme row hermes-agent-v0-19-quicksilver added to /themes.md; this is distinct from the existing MiniMax-m3 row, which is about the M3 model itself.

MCP 2026-07-28 revision finalization (adjacent watchlist): The Register, 2026-07-23 — score 0.059. MCP maintainers plan to finalize the 2026-07-28 protocol revision, not backward-compatible, breaks with stateful past. Single-source, low Tavily score, but directly relevant to OpenWiki's MCP server architecture. Folded into the new hermes-agent-v0-19-quicksilver theme row's Evidence column rather than spawning a separate row.

3D bioprinted organoid reviews + Pluristyx hepatocyte manufacturing — folded into class-organoid-3d-bioprinting

Two same-week review papers and one iPSC + aerospace clinical-grade hepatocyte manufacturing press release re-anchor the existing application-domain theme row:

All three items fold into the existing class-organoid-3d-bioprinting row. Last seen refreshed to 2026-07-27; evidence count increased.

3Brain / Cellink / CellShot / installed-base / RAGFlow lanes — no new vendor-anchored evidence; Tavily answer-text mis-attribution recurs

  • 3Brain CorePlate MEA 2026: the Nature portable semi-dry EEG device paper reappears at score 0.187. Tavily's answer text again labels it "3Brain CorePlate MEA 2026" validated in a brain-computer-interface study — the underlying paper is about a portable EEG headset, not 3Brain MEA chips. Do not promote as 3Brain evidence. Other hits in this lane (News-Medical FlatMux imaging, Precision Neuro BCI, BioTechniques bi-weekly) are application-domain only.
  • Cellink BIO X bioprinter 2026: no direct Cellink result. Top hits are Velo3D Livermore campus, Lumafield Mars X-ray inspection, AI protein engineering model, Repligen–BioLife ($1.5bn cell-therapy acquisition). All unrelated to Cellink BIO X / BIONOVA X / Lumen X. Application-domain only.
  • CellShot / CellPick bioprinter 2026: no Femtobiomed result. Cellares–Papillon PPL-001 partnership (Cellares is unrelated to Femtobiomed) at score 0.201, CCDx whole-cell genomic profiling at 0.164, Nature MO:BOT paper re-mention at 0.074. Tavily answer text honestly says "The CellShot CellPick bioprinter 2026 is not directly mentioned in the provided data sources."
  • labs CelVivo ClinoStar installed base 2026: no direct result. Cepheid GeneXpert third-generation ADLM 2026 (score 0.112) dominates the top slot and is unrelated to CelVivo installed-base. Query phrasing continues to drift toward competitor/molecular-diagnostic content.
  • China cell therapy 3D bioprinting regulation 2026: re-anchors the existing /commitments.md china-cde-cell-gene-therapy-rules-2026 item. Top result: Roots Analysis Cell Therapy Manufacturing Market Size 2035 (0.669) re-mentioning Merck's $11.3B Bio-Techne acquisition. Second hit: cisema.com (0.666) — the same China CDE source as the 2026-07-26 18:07 pull.
  • OpenWiki connectors Tavily RAGFlow 2026: Tavily recall still broken. Returns AWWA ACE26 SmartBall X pipeline inspection, MBT cybersecurity coverage, Seatrade S-100, OpenTug agricultural shipping, iVeena FDA meeting, RightShip–NorthStandard, LEO satellite scaling, Tokyo fashion show. None of the 8 results touches Robin's actual stack.
  • agent personal memory wiki 2026: iTnews State of Data & AI 2026 (Australian enterprise agentic AI, 0.403), LangChain4j self-building-agent (0.168), Times of Israel Cursor CVE-2026-48124 (0.121), Ad Age small-agency awards (0.103 / 0.103 / 0.083 / 0.082), MCP 2026-07-28 revision (0.059, see above). Only the MCP item is actionable; the rest is noise or adjacent to Robin's stack without direct relevance.

Synthesis result

  • Two new scope-aligned findings: (a) CelVivo ClinoReactor + TheWell Bioscience xeno-free workflow (vendor-anchored, first time in any Tavily pull); (b) Hermes Agent v0.19 Quicksilver (workflow tooling, source-backed).
  • Two supporting application-domain items folded into the existing class-organoid-3d-bioprinting row: two 3D-bioprinted organoid review papers (Oxford 2026-07-27, Sage 2026-07-22) and Pluristyx iPSC + aerospace hepatocyte manufacturing press release (2026-07-27).
  • Tavily answer-text mis-attribution pattern persists on the 3Brain and Cellink lanes; this is the third pull in a row where the answer text names a vendor that is not actually in the underlying source. Continue treating Tavily answer text as untrusted; only the underlying URLs are evidence.
  • OpenWiki / RAGFlow lane still produces zero relevant results after four pulls. Consider dropping this lane from future Tavily runs unless the query is rephrased to anchor on product names (e.g. "RAGFlow 0.x release notes" instead of "OpenWiki connectors Tavily RAGFlow").

Source coverage (cumulative)

  • Pull 1: fetched 2026-07-26T17:39:11Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T17-38-33-286Z/web-search-results.json
  • Pull 2: fetched 2026-07-26T18:07:27Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T18-07-14-335Z/web-search-results.json
  • Pull 3: fetched 2026-07-26T18:16:21Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T18-16-06-804Z/web-search-results.json
  • Pull 4: fetched 2026-07-27T18:04:46Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-27T18-04-01-259Z/web-search-results.json
  • Pull 5: fetched 2026-07-28T18:04:26Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-28T18-03-43-560Z/web-search-results.json
  • Queries: pulls 1, 2, 4, 5 = 10 queries each; pull 3 = 6 queries (vendor-anchored only)
  • Instance: web-search-1

2026-07-28 18:04 pull

Fifth Tavily pull, run as a stand-alone openwiki personal --update source ingest. All 10 queries re-run. Two lanes produced genuinely new material evidence (China Order No. 818 regulatory shift; LLM Wiki + OKF shared-memory architecture cluster). The China CDE classification item, CelVivo/TheWell partnership, and Hermes v0.19 Quicksilver rows were not re-anchored in this pull — they remain pinned via /commitments.md and the hermes-agent-v0-19-quicksilver / china-cde-cell-gene-therapy-rules-2026 theme rows. Tavily answer-text mis-attribution continues on the 3Brain, Cellink, and Hermes lanes.

China Order No. 818 — accelerated clinical-translation pathway — source-backed

This is a new Chinese regulatory signal distinct from the existing CDE classification item. Order No. 818 (effective 2026-05-01) creates an accelerated pathway for advanced biomedical technologies — including cell therapy and 3D bioprinting — to reach clinical translation at qualified hospitals after demonstrating safety and preliminary efficacy.

  • LinkedIn (BetaLife SG), 2026-07: #ipsc #betalife #celltherapy #ipsc #regenerativemedicine #diabetes #clinicaltranslation #biotechnology #xiamen. Score 0.779. Explicitly references "Order No. 818, effective May 1, 2026. The regulation introduces an accelerated pathway for eligible advanced biomedical technologies towards regulated clinical translation at qualified hospitals after demonstrating safety and preliminary efficacy." BetaLife (a Singapore-based iPSC company) names this in their post; they cite it as directly relevant to their China clinical-translation journey.
  • Roots Analysis, 2026-07: Cell Therapy Manufacturing Market Size 2035. Score 0.669. Re-mention of the broader China cell-therapy regulatory landscape (Merck–Bio-Techne $11.3B acquisition, CARsgen China approval). Not an Order No. 818 citation directly, but corroborates the pattern of accelerating China cell-therapy regulatory activity in the same window.
  • Tavily answer text independently synthesizes: "China's regulation under Order No. 818, effective May 1, 2026, introduces an accelerated pathway for advanced biomedical technologies, including cell therapy and 3D bioprinting, towards clinical translation at qualified hospitals after demonstrating safety and preliminary efficacy." This is the same content as the BetaLife post — single primary source, with Tavily's synthesis echoing it.

Robin relevance: HIGH for the Chinese pharma R&D / CDMO / biotech customer base. Order No. 818 is the clinical-translation pathway counterpart to the CDE classification item (which is about CMC planning). Both items matter: classification scope drives what dossier content vendors need to assemble, and the clinical-translation pathway drives which hospitals can host the first-in-human studies. Together they shape how Femtobiomed positions CelVivo-class bioreactors and 3Brain-class MEA platforms into Chinese accounts.

Why source-backed (not watchlist): the item is published regulatory text (Order No. 818, effective 2026-05-01), not a rumor; BetaLife is a credible industry-actor source citing it in their own clinical-translation context; the Tavily synthesis is consistent with the BetaLife wording. Treat as source-backed pending direct NMPA / State Council corroboration. Promoted to /themes.md as a new row china-order-no-818-clinical-translation and to /commitments.md as a verification item.

LLM Wiki + OKF / shared-agent-memory cluster — source-backed (workflow tooling, low priority)

The agent personal memory wiki 2026 query returned five same-week sources on a single coherent architecture: a shared agent-memory layer using Andrej Karpathy's LLM Wiki + Google's Open Knowledge Format (OKF) + Model Context Protocol (MCP), positioned to let "every Local AI … share ONE permanent memory." This is directly adjacent to OpenWiki's role.

Robin relevance: workflow-tooling, low priority — but the cluster is substantially more corroborated than the prior HN-only signal. Five distinct publishers (YouTube creator, SaaS vendor, GitHub, LinkedIn, Reddit) and one adjacent benchmark in the same week all converge on the same OKF + MCP shared-memory architecture. Combined with the existing agent-memory-architecture row's three HN Show HN items, the topic now has 8+ distinct sources. Promote agent-memory-architecture from watchlist to source-backed and refresh Last seen to 2026-07-28.

3Brain / Cellink / CellShot / installed-base / Hermes lanes — no new vendor-anchored evidence; Tavily answer-text mis-attribution recurs

  • 3Brain CorePlate MEA 2026: the Nature portable semi-dry EEG device paper reappears at score 0.187. Tavily answer text again labels it "3Brain CorePlate MEA 2026 validated in a brain–computer interface study" — the underlying paper is about a portable EEG headset, not 3Brain's MEA chips. This is the fourth pull in a row with the same mis-attribution. Do not promote as 3Brain evidence.
  • Cellink BIO X bioprinter 2026: Tavily answer text labels the Roche ADLM 2026 intelligent lab solutions press release (0.082) as "Cellink BIO X bioprinter at ADLM 2026" — the underlying source is Roche, not Cellink. The remainder of the lane is industry context (Nova Biomedical–NanoCellect, Massive Bio–GELL, Lumafield Mars X-ray, Repligen–BioLife, BioTechniques bi-weekly). All unrelated to Cellink BIO X / BIONOVA X / Lumen X.
  • CellShot / CellPick bioprinter 2026: Tavily honestly says "the CellShot CellPick bioprinter 2026 is not directly mentioned in the provided data sources." Top hits are CCDx whole-cell genomic profiling (0.164), Nova Biomedical–NanoCellect (0.062), AI protein engineering model (0.059), Towards Healthcare cell-and-gene-therapy intelligence infrastructure (0.052), Pluristyx re-mention (0.042). No Femtobiomed vendor signal.
  • labs CelVivo ClinoStar installed base 2026: no direct result. Cepheid GeneXpert third-generation ADLM 2026 (score 0.112) and Roche ADLM 2026 (0.143) dominate the top slots and are unrelated to CelVivo installed-base. Query phrasing continues to drift toward competitor/molecular-diagnostic content.
  • Hermes Agent MiniMax M3 changelog 2026: Tavily answer text returns Apple product news ("Mismatched M6 and M5 Pro chips", iOS 26.6, POCO Launcher 7.50) — no Hermes Agent, no MiniMax M3, no Hermes changelog in the underlying URLs. Top hit: MacRumors Next Mac Mini article at 0.074. The v0.19 Quicksilver signal from the prior pull remains the most recent Hermes row; this lane produced nothing new in this 24h window.
  • OpenWiki connectors Tavily RAGFlow 2026: Tavily recall still broken. Returns AWWA ACE26 SmartBall X (0.025), Bizora advisory group / Billtrust MCP server (0.026), OpenTug shipping (0.017), Sunvega AI spatial-design workspace (0.016), RightShip maritime (0.016), Inland Tank-Barge Safety Guide (0.015). Only the Billtrust MCP server item is mildly adjacent (MCP-server ecosystem); the rest is unrelated to OpenWiki / Gitea / Wiki.js / RAGFlow / NocoDB / SeaFile. Recommend dropping this lane from future Tavily runs unless the query is rephrased to anchor on product names.
  • organ-on-chip pharma collaboration 2026: the Nature Gut-on-a-Chip culturomics paper (0.986) is the same item surfaced in the 2026-07-26 17:39 pull. Application-domain signal only — folds into the class-organoid-3d-bioprinting row without a new evidence note.

Synthesis result

  • Two new scope-aligned findings:
    1. China Order No. 818 — clinical-translation pathway for cell therapy + 3D bioprinting at qualified hospitals, effective 2026-05-01. Source-backed on a single primary source (BetaLife LinkedIn) with Tavily synthesis corroboration. Distinct from the existing china-cde-cell-gene-therapy-rules-2026 item (classification vs clinical pathway). Promoted to /themes.md as new row china-order-no-818-clinical-translation and to /commitments.md as a verification item.
    2. LLM Wiki + OKF shared-memory cluster — five Tavily sources + three prior HN sources all converge on Karpathy's LLM Wiki + Google OKF + MCP shared-memory architecture. Directly adjacent to OpenWiki's role. Promotes existing agent-memory-architecture row from watchlist to source-backed.
  • No new vendor-anchored evidence on CelVivo, 3Brain, Cellink, CellShot/TriArm, or Hermes this pull. The prior vendor-anchored items (CelVivo+TheWell, Hermes v0.19 Quicksilver) remain on disk and referenceable; the Hermes row's Last seen is not refreshed because the underlying URLs in this pull returned Apple-product noise.
  • Tavily answer-text mis-attribution pattern persists on 3Brain (4th pull), Cellink (4th pull), and Hermes (1st pull). This is a Tavily-side quality issue; treat Tavily answer text as untrusted and only the underlying URLs as evidence. Continued recommendation: narrow future pulls to vendor-name-anchored queries only.
  • OpenWiki / RAGFlow / agent-memory lane behavior changed. The lane still produces zero OpenWiki/RAGFlow/SeaFile/NocoDB/Gitea results, but the agent-personal-memory-wiki lane is now high-signal for the OKF/LLM Wiki architecture — strong enough to promote the existing agent-memory-architecture row.

2026-07-29 18:03 pull

Sixth Tavily pull, run as a stand-alone openwiki personal --update source ingest. All 10 queries re-run. Three lanes produced material new evidence: Cellink BIO X Gen 3 first-time vendor-anchored signal; China CGT regulatory landscape material updates (Merck–Bio-Techne, CARsgen satri-cel, gene-editing trial death + backlash); Hermes Agent v0.19 documentation continues (configuration.md, api-server.md). The CelVivo/TheWell xeno-free and China Order No. 818 items remain pinned in /commitments.md. The agent-memory-architecture cluster continues to grow. Tavily answer-text mis-attribution persists on Q2/Q3 (3Brain / Cellink) but the underlying URLs are now vendor-anchored for Cellink — a first.

Cellink BIO X Gen 3 / BIO X6 — first vendor-anchored Cellink signal — source-backed

This is the first vendor-anchored Cellink BIO X / BIO X6 / BIO X Gen 3 signal in any Tavily pull. Prior pulls returned only MO:BOT, Roche, Cepheid, Velo3D, Cellares-Papillon, or generic bioprinting market reports — never Cellink product names in a vendor/customer context. Three same-week sources confirm Cellink product activity:

  • LinkedIn (Nuclear Mechano-Oncology), no exact date in 2026-07: BIO X Gen 3 Bioprinter Installed and Trained. Score 0.601. A customer lab (Nuclear Mechano-Oncology) announces the install + first hands-on training of a BIO X Gen 3 bioprinter, with team members Ines Papak, Kamil Łangowski, Julia Jała named. Positions BIO X Gen 3 as "an important addition to our work on advanced 3D cell culture models and the development of more physiologically relevant cancer research platforms."
  • LinkedIn (CELLINK official channel), 2026-07-28: From Star Trek to the Clinic: 3D Bioprinting Facility is Engineering Molecules for Patient Implantation. Score 0.287. CELLINK's own organization page (26,186 followers) highlights the University of Miami 3D Bioprinting Facility using CELLINK's BIO X6 in the toolkit for tissue engineering and patient-specific implants. Companion article from InventUM.
  • LinkedIn (Biomedical 3D Printer Market report), 2026-07-28: Biomedical 3D Printer Market Size and Growth at a 4.7% CAGR from 2026 to 2033. Score 0.659. Third-party market report explicitly names Cellink as a major player with "a significant uptick in their revenue stream" following "strategic acquisitions and increased market penetration" and notes Cellink's "focus on sustainable and customizable bioinks."
  • apellaser.ro, 2026-07-24: How to Choose a 3D Bioprinter: Practical Selection Guide. Score 0.303. Independent practical guide explicitly names "BIO X Gen 3 is the general-purpose choice for laboratories that need flexible extrusion and up to three interchangeable printheads or tools." Vendor-anchored reference, not a press release.
  • Tavily answer text describes "The Cellink BIO X bioprinter, specifically the Gen 3 model, is a versatile tool for laboratories requiring flexible extrusion and up to three interchangeable printheads" — this time the answer text correctly identifies Cellink product naming (though it includes hallucinated "Gen 3" details in some phrases; the underlying URLs are the source of truth).

Robin relevance: HIGH. First vendor-anchored Cellink signal after 5 prior pulls of zero Cellink product mentions. The Nuclear Mechano-Oncology install is an Eastern European customer reference; the U. Miami BIO X6 mention is the same University of Miami 3D Bioprinting Facility that has been a recurring Cellink reference in industry press; the market report independently corroborates Cellink revenue growth. Promoted to /commitments.md as cellink-bio-x-gen3-customer-evidence for next-vendor-check verification (parallel structure to the CelVivo+TheWell row).

China cell & gene therapy regulatory landscape — material updates — source-backed

The Q7 lane surfaced four distinct new items that materially update the existing /commitments.md china-cde-cell-gene-therapy-rules-2026 and china-order-no-818-clinical-translation items. The gene-editing trial death + regulatory backlash is the most consequential — it directly affects how Robin positions 3Brain MEA + CelVivo ClinoReactor + Cellink BIO X for Chinese pharma R&D / CDMO / biotech customers.

  • Roots Analysis, 2026-07-24: Cell Therapy Manufacturing Market Size 2035. Score 0.669. Two new data points from the same Roots Analysis page: (a) June 2026: Merck agreed to acquire Bio-Techne for ~$11.3B to strengthen life-science capabilities across bioprocessing, advanced therapeutics, and integrated workflow solutions for cell-and-gene-therapy developers; (b) June 2026: CARsgen Therapeutics received China NMPA approval for satri-cel, a CAR-T therapy for solid-tumor stomach cancer — described as "an important milestone for solid tumor CAR-T therapies" expected to increase demand for specialized CAR-T manufacturing in Asia-Pacific.
  • BioSpace, 2026-07-27: Summit, Merck must navigate new regulatory terrain in China-first cancer landscape. Score 0.535. Frames the broader pattern of China-first cancer-drug development: Stifel analysts (2026-07-22 note) argue the HARMONi 2-year follow-up data is "a strong counter" to the "China data would not translate" bear argument. Implications for CDMO and instrument vendors supporting both Western and China-first pipelines.
  • Straits Times, 2026-07-24: Patient death in China gene-editing trial draws fire: Journal. Score 0.313. A patient (later confirmed as a 6-year-old girl in follow-up coverage) died in an experimental gene-editing trial in China; the case is drawing published scrutiny of China's gene-therapy regulatory regime.
  • LiveScience, 2026-07-24: An experimental gene therapy killed a 6-year-old girl in China. Her parents are seeking accountability. Score 0.145. Investigation-level coverage: raises "questions about the country's gene therapy regulations."
  • SCMP, 2026-07-29: Is China's biotech boom at risk? Fear of policy backlash after death in gene-editing trial. Score 0.203. Frames the same death as a potential inflection point for China's biotech regulatory regime — "Fear of policy backlash." Published same day as this Tavily pull, which is what surfaces it.

Robin relevance: HIGH (the gene-editing trial death item especially). The Merck–Bio-Techne acquisition and CARsgen satri-cel approval are positive indicators of the China CGT manufacturing environment. The gene-editing trial death + published regulatory scrutiny is the inverse signal: it could foreshadow stricter CDE / NMPA / hospital-level oversight, which would affect (a) qualification timelines for the CellShot-TriArm and ClinoReactor-class deals Robin has in flight, and (b) which "qualified hospitals" under Order No. 818 remain eligible. Promoted to /commitments.md as china-cgt-2026-july-developments to track this as a single follow-up item.

Organ-on-chip pharma collaboration 2026 — source-backed (application-domain)

The Q4 lane returned two strong same-week items on organ-on-chip / pharma collaboration:

Robin relevance: application-domain only — folds into the existing class-organoid-3d-bioprinting row. CN Bio / Emulate are not one of Robin's 4 vendor lines, but both are competitive/positioning signal for CelVivo-class bioreactors at pharma R&D accounts. NASA AVATAR is a high-visibility OOC application milestone.

Hermes Agent v0.19 documentation refresh — source-backed (workflow tooling, low priority)

Q8 returned two NousResearch/hermes-agent repo documentation updates and one third-party M3-vs-OpenClaw comparison. The docs confirm v0.19+ work is still landing in the 2026-07-26 → 2026-07-29 window — same row as the v0.19 Quicksilver signal, more sources.

  • GitHub (NousResearch/hermes-agent configuration.md), 2026-07-26: Iteration Budget. Score 0.590. Documents the iteration-budget behavior change: "earlier builds warned the model at 70%/90% budget, which caused models to abandon complex tasks prematurely and was removed in April 2026." Now at default 500 turns, Hermes injects one wrap-up message at 500/500 with a single grace call. Story-worthy because it is a deliberate quality change, not just a number.
  • GitHub (NousResearch/hermes-agent features/api-server.md), 2026-07-27: POST /v1/runs/{run_id}/stop + /approval endpoints. Score 0.367. Documents the new /v1/runs/{run_id}/stop and /v1/runs/{run_id}/approval endpoints (returning {"status": "stopping"} and resolving approval policies). Sample JSON now uses "model":"MiniMax-M3" with provider "minimax" — M3 is the documented default.
  • MyClaw.ai, 2026-07-29: OpenClaw vs MiniMax Agent: Which AI Agent Should You Use in 2026?. Score 0.543. Third-party comparison: OpenClaw supports MiniMax through OAuth with a Token Plan or API key. M3 handles primary reasoning; M2.7 variants remain available. Multimodal (image, video, music, speech, web search) supported across M3 and M2.7.
  • Instagram (Sriram Varadharajan), no exact date in 2026-07: AI COMMAND CENTER TRIAL REEL — MiniMax M3 announcement. Score 0.497. Reels text references MiniMax M3 launch ("longer context, capability uplift over M2") and open-source readiness. Adjacent to MiniMax-M3 theme row.

Robin relevance: WORKFLOW TOOLING (low priority). The configuration.md change is a Hermes-side behavior update Robin's daily-driver stack benefits from; the api-server.md endpoints are runtime-control surfaces OpenWiki's MCP integration could exploit; MyClaw.ai confirms MiniMax M3 as the operational model for both OpenClaw and Hermes. Folded into the existing hermes-agent-v0-19-quicksilver and MiniMax-m3 theme rows — refreshes Last seen but does not spawn a new row.

Agent-memory-architecture cluster grows — source-backed (workflow tooling, low priority)

Q10 returned four new sources that further corroborate the existing agent-memory-architecture theme row. Combined with the prior 5 Tavily + 3 HN sources, the cluster now has 12+ distinct publishers converging on shared / open-format / persistent agent-memory architectures:

  • HPCwire, 2026-07-28: Exabase Reports State-of-the-Art Results on BEAM Memory Benchmark. Score 0.624. Exabase M-1 achieves highest reported score at every scale: 76.9% at 100K tokens, 75.0% at 1M tokens, 68.0% at 10M tokens, using Gemini 3 Flash (a model "up to six times cheaper and faster" than Gemini 3 Pro used by every other leading system). 20% fewer tokens per query than next-best system.
  • Hackernoon (Moorcheh.ai CTO), 2026-07-28: Agent Memory Has a Lock-In Problem. Open Formats Are How We Fix It.. Score 0.605. Frames the lock-in problem explicitly: "Your agent has been in production for a year. … thousands of memories: user preferences, resolved decisions, corrections, domain facts. Now you want to move to a different memory system — better retrieval, better pricing, whatever. What's your migration path?" Argues for Diffability ("git diff shows exactly what your agent learned between two commits"), Reviewability ("Memory changes can go through pull requests like code"), and Auditability ("Regulated environment? Your …"). This is the most explicit OpenWiki-aligning post yet — pull-request review of agent memory is exactly what OpenWiki's synthesis workflow does.
  • Towards Data Science, 2026-07-24: Context Windows Forget What Matters — I Built a Usage-Reinforced Decay Engine for AI Agent Memory. Score 0.576. Uses Ebbinghaus forgetting curve (1885) to design a spaced-repetition decay engine for agent memory. Cites the open-source YourMemory project (Mishra, 2026) as another Ebbinghaus-forgetting-curve implementation. Robin-relevant because OpenWiki's wiki synthesis itself is a form of spaced-repetition knowledge curation.
  • The Register, 2026-07-29: MinIO pitches persistent memory for agents with work to finish. Score 0.425. MinIO AIStor Memory for long-running multi-step agent workflows. Example use cases: software engineering agents across large codebases; deep research spanning hours or days; human-in-the-loop workflows that pause and resume; enterprise AI systems handling regulated data. The piece argues "agent-generated work accumulates, memory created for individual agents can become a shared organizational record built by humans and machines" — and that where that record lives is the architectural question OpenWiki sits at.

Robin relevance: WORKFLOW TOOLING (low priority). The cluster is now 12+ sources. The Hackernoon/Moorcheh.ai piece is the strongest single source for OpenWiki alignment (pull-request review of agent memory maps 1:1 onto OpenWiki's synthesis). The MinIO piece confirms enterprise infrastructure vendors are now treating "shared organizational memory built by humans and machines" as a product category. Refreshes agent-memory-architecture Last seen to 2026-07-29 and adds to evidence count.

3Brain / CellShot / installed-base / OpenWiki-RAGFlow / Tavily answer-text quality — same pattern

  • 3Brain CorePlate MEA 2026: Nature portable semi-dry EEG device paper reappears at score 0.187 — fifth pull in a row with the same mis-attribution. Tavily answer text again labels it "3Brain CorePlate MEA 2026 … validated for its application in brain–computer interface solutions." Underlying paper is a portable EEG headset, not 3Brain MEA chips. Do not promote as 3Brain evidence.
  • Cellink BIO X bioprinter 2026: as noted above, this pull is the first to return real Cellink product evidence. Tavily answer text was finally correct on the Cellink side this time ("Cellink BIO X bioprinter, specifically the Gen 3 model, is a versatile tool for laboratories requiring flexible extrusion and up to three interchangeable printheads").
  • CellShot / CellPick bioprinter 2026: Tavily honestly says "The CellShot CellPick bioprinter 2026 is not mentioned in the provided data sources." Top hit is GEN "Large Bioprinted Tissues Get a Precision Boost" (2026-07-29 12:00:52 GMT, score 0.259) — application-domain news, no Femtobiomed vendor signal. The same GEN article reappears in Q1 (0.037), Q2 (0.032), and Q5 (0.259). Worth a note in class-organoid-3d-bioprinting evidence column.
  • labs CelVivo ClinoStar installed base 2026: Tavily answer text returns a hallucinated claim: "As of today, July 29, 2026, the CelVivo ClinoStar is being installed in new A-Level (H2) science labs, such as the one opening in Eclat @ Henderson in August 2026." No URL in the result set mentions CelVivo, ClinoStar, A-Level, H2, Eclat, or Henderson. This is a fabricated Tavily answer — flag and ignore. The actual top hits are Instagram reels and the UFS Alzheimer's story, all unrelated to CelVivo.
  • Hermes Agent MiniMax M3 changelog 2026: as noted above — first pull with non-noise Hermes/M3 evidence (configuration.md, api-server.md, MyClaw.ai, Instagram reel). Promotes the existing rows instead of spawning new ones.
  • OpenWiki connectors Tavily RAGFlow 2026: recall still broken. Returns Roche ADLM 2026 (0.043), Nature chemical-reaction pathway algorithm (0.029), SmartBall X water infrastructure (0.025), exposure-management AI-attack cybersecurity (0.023), HID workforce unit transfer (0.019), GEN "Downstream Purification Platform Breaks Complex Vector Bottleneck" (0.017), RightShip maritime (0.016), insurance payment (0.016). Only the GEN vector-bottleneck item is mildly adjacent (cell-and-gene-therapy manufacturing); the rest is noise. Recommend dropping this lane from future Tavily runs.

Synthesis result

  • Three new scope-aligned findings:
    1. Cellink BIO X Gen 3 / BIO X6 customer evidence — first vendor-anchored Cellink signal in any Tavily pull. Multi-source (Nuclear Mechano-Oncology LinkedIn install, CELLINK official LinkedIn BIO X6 at U. Miami, third-party market report, appellaser selection guide). Promoted to /commitments.md as cellink-bio-x-gen3-customer-evidence.
    2. China CGT regulatory landscape updates — Merck–Bio-Techne $11.3B acquisition (June 2026); CARsgen satri-cel CAR-T approval for stomach cancer (June 2026); gene-editing trial death + regulatory backlash (Straits Times / LiveScience / SCMP coverage 2026-07-24 → 2026-07-29). Promoted to /commitments.md as china-cgt-2026-july-developments to track the gene-editing-death + China-biotech-backlash signal alongside the existing classification and Order No. 818 items.
    3. Hermes Agent v0.19 docs continue — configuration.md iteration-budget behavior change (April 2026, documented 2026-07-26) + api-server.md new stop / approval endpoints (2026-07-27). Refreshes Last seen for hermes-agent-v0-19-quicksilver. MyClaw.ai confirms MiniMax M3 + M2.7 as the operational models for both OpenClaw and Hermes — refreshes Last seen for MiniMax-m3.
  • One application-domain cluster strengthens: organ-on-chip (CN Bio + Ligand + Sequel Med Tech; NASA AVATAR + Emulate). Folds into the existing class-organoid-3d-bioprinting row without spawning a new theme.
  • Agent-memory-architecture cluster grows to 12+ distinct sources. Hackernoon/Moorcheh.ai "Agent Memory Has a Lock-In Problem" is the strongest single OpenWiki-aligning source yet. Refreshes Last seen for agent-memory-architecture.
  • Tavily answer-text mis-attribution continues on Q2 3Brain (5th pull). This is now a Tavily-side quality issue worth flagging in connector notes.
  • New Tavily hallucination pattern on Q6: the Tavily answer text invented a specific claim about CelVivo ClinoStar being installed in "new A-Level (H2) science labs, such as the one opening in Eclat @ Henderson in August 2026." No underlying URL supports this. Treat Tavily answer text on the installed-base query as fabrication and ignore.
  • No 3Brain / CellShot-TriArm / OpenWiki-RAGFlow direct evidence in this pull.

Source coverage (cumulative)

  • Pull 1: fetched 2026-07-26T17:39:11Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T17-38-33-286Z/web-search-results.json
  • Pull 2: fetched 2026-07-26T18:07:27Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T18-07-14-335Z/web-search-results.json
  • Pull 3: fetched 2026-07-26T18:16:21Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T18-16-06-804Z/web-search-results.json
  • Pull 4: fetched 2026-07-27T18:04:46Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-27T18-04-01-259Z/web-search-results.json
  • Pull 5: fetched 2026-07-28T18:04:26Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-28T18-03-43-560Z/web-search-results.json
  • Pull 6: fetched 2026-07-29T18:03:26Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-29T18-02-29-119Z/web-search-results.json
  • Pull 7: fetched 2026-07-30T18:04:41Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-30T18-03-34-547Z/web-search-results.json
  • Queries: pulls 1, 2, 4, 5, 6, 7 = 10 queries each; pull 3 = 6 queries (vendor-anchored only)
  • Instance: web-search-1

2026-07-30 18:04 pull

Seventh stand-alone Tavily pull; all 10 queries re-ran. The material additions are the first credible direct 3Brain result in this lane, lower-confidence CelVivo ClinoStar campaign snippets, authoritative FDA organ-on-chip/NAMs context, and continued Hermes/OpenWiki/agent-memory evidence. Cellink, CellShot, and China-policy results were predominantly re-mentions or attribution noise.

3Brain CorePlate conference and application positioning — confirmed vendor signal

  • 3Brain organization material via LinkedIn, surfaced with a 2026-07-25 result: ISSCR 2026 / CorePlate-enabled HD-MEA campaign (score 0.857) positions CorePlate for high-resolution, scalable functional readouts from iPSC-derived neuronal models, brain organoids, assembloids, and neuronal/cardiomyocyte screens; it names ISSCR booth 412.
  • 3Brain company LinkedIn: 3Brain AG (score 0.839) adds ELRIG Drug Discovery booth 4 and describes multi-well HD-MEA use for mechanistic studies and higher-throughput screening across neuronal/cardiac models, 3D spheroids, and brain organoids. The page aggregates multiple posts, so individual event timing still needs a direct vendor check.
  • 3Brain official site: High-Density Microelectrode Array (score 0.689) independently anchors CorePlate 3D / Accura-3D, brain-organoid and Pharma-on-Chip applications, and BrainWave 6. The pull contains no new CorePlate load-force, Sample Holder Set, or patent detail.
  • Robin relevance: first credible direct 3Brain evidence after five pulls dominated by an unrelated EEG-paper mis-attribution. Added /commitments.md#3brain-coreplate-2026-conference-positioning-verify-current-coreplate-campaign-and-retrieve-application-material-on-next-3brain-check for the required next-vendor-check verification.

CelVivo ClinoStar / ClinoStar 2 campaign snippets — watchlist

  • Instagram snippets: ClinoStar webinar copy (score 0.335) describes clinostat-based simulated microgravity; NexUs Locus live-demo copy (published 2026-07-24; score 0.291) promises on-site growth of larger, more physiologically relevant organoids; a separate ClinoStar 2 post (score 0.188) positions the system for NAMs and human-based drug-safety/efficacy evaluation.
  • Account provenance and dates are incomplete in the result set, and the query answer extrapolates an “installed base” that none of the URLs documents. One duplicate result carried a malformed/spam-like query string and was discarded.
  • The TheWell Bioscience xeno-free guide reappeared but adds nothing beyond the existing celvivo-clinoreactor-thewell-bioscience-xeno-free commitment.
  • Robin relevance: potentially useful current CelVivo messaging, but not proof of a launch, installation, or customer win. Added /commitments.md#celvivo-clinostar-2-nams-demo-2026-verify-product-naming-and-campaign-provenance-on-next-celvivo-check as a verification lead.

Organ-on-chip, bioprinting, and regulatory context

Workflow tooling and agent memory — source-backed, low priority

  • NousResearch Hermes Agent docs: api-server.md (score 0.729) now exposes a July 2026 per-profile API_SERVER_KEY breaking-change warning and a runs API for long-form sessions, extending the stop/approval endpoint evidence captured in pull 6. A third-party Hermes Atlas report summarizes broader July changes; ReleaseBot's OpenClaw notes are not treated as Hermes release evidence.
  • OpenWiki official repository: langchain-ai/openwiki (score 0.416) is finally returned by the previously noisy OpenWiki/RAGFlow query and confirms the current connector set and user-authored instruction-brief behavior. It is a discovery/retrieval improvement, not evidence of a new OpenWiki release; no direct RAGFlow shift appeared.
  • LLM-wiki pattern: arXiv 2607.24759v1 (score 0.792) explicitly describes an LLM-maintained interlinked Markdown wiki between raw sources and agents; LLM Wiki v2 surfaced on 2026-07-30 (score 0.759) adds segmentation, librarian/retrieval, and schema-design discussion.
  • Enterprise agent memory: MinIO's AIStor Memory announcement (2026-07-29; score 0.576) and SiliconANGLE coverage (2026-07-30; score 0.524) corroborate the persistent, governed memory category already indexed as agent-memory-architecture.

Exclusions and synthesis result

  • Cellink: Tavily's answer attributes the MDPI volumetric-bioprinting paper to BIO X, but the underlying result excerpt does not name CELLINK. Faryal Zahid's portfolio names Lumen X / BIO ONE / BIO X manuals but is documentation-history context, not a release or customer win. The existing Cellink commitment is unchanged.
  • Femtobiomed: the CellShot/CellPick query returned only a generic consumer 3D-printing article; its CellShot attribution is unsupported. No CellShot, CellPick, or TriArm evidence was promoted.
  • Promoted: two vendor-verification commitments (3Brain and CelVivo). Not promoted: no new theme row, open question, personal-logistics item, or China-regulatory commitment.
  • Coverage: fetched 2026-07-30T18:04:41.115Z; 10 queries; raw ~/.openwiki/connectors/web-search/raw/2026-07-30T18-03-34-547Z/web-search-results.json; instance web-search-1.

2026-07-31 18:04 pull

Eighth Tavily pull, run as a stand-alone openwiki personal --update source ingest. All 10 queries returned a structured "error": "fetch failed" — no usable evidence this cycle. The same queries succeeded in pulls 1–7, so this looks like a Tavily-side / upstream network outage rather than a query-phrasing or scope problem. No theme refresh, no new commitments, no new open questions.

Per-query result

Every query in the 10-query lane returned the same structured error (no answer text, no result URLs):

  • CelVivo ClinoReactor spheroid 2026 — error
  • 3Brain CorePlate MEA 2026 — error
  • Cellink BIO X bioprinter 2026 — error
  • organ-on-chip pharma collaboration 2026 — error
  • CellShot CellPick bioprinter 2026 — error
  • labs CelVivo ClinoStar installed base 2026 — error
  • China cell therapy 3D bioprinting regulation 2026 — error
  • Hermes Agent MiniMax M3 changelog 2026 — error
  • OpenWiki connectors Tavily RAGFlow 2026 — error
  • agent personal memory wiki 2026 — error

Synthesis result

  • No new vendor-anchored or application-domain evidence. Tavily returned a structured fetch failed error on every query. All seven prior pulls remain the canonical evidence base; no wiki synthesis update is warranted this run.
  • Operational note for the connector. This is the first fully-failed pull since the Tavily lane was activated on 2026-07-26. If the next pull also fails, consider checking TAVILY_API_KEY validity, Tavily status page, or rate-limit posture before continuing to schedule the lane.
  • Coverage: fetched 2026-07-31T18:06:36.672Z; 10 queries (all failed); raw ~/.openwiki/connectors/web-search/raw/2026-07-31T18-04-55-956Z/web-search-results.json; instance web-search-1.

2026-08-01 18:09 pull

Gap-fill. Pull 9 was ingested on 2026-08-01 between Tavily's last documented failed run (2026-07-31 pull 8) and this current run, but the prior openwiki personal --update cycle was git-repo-only and did not record a Tavily section. Pulling the raw data forward here so the connector's outage streak is auditable. All 10 queries returned a structured "error": "fetch failed" — same pattern as pull 8.

Per-query result

Every query in the 10-query lane returned the same structured error (no answer text, no result URLs):

  • CelVivo ClinoReactor spheroid 2026 — error
  • 3Brain CorePlate MEA 2026 — error
  • Cellink BIO X bioprinter 2026 — error
  • organ-on-chip pharma collaboration 2026 — error
  • CellShot CellPick bioprinter 2026 — error
  • labs CelVivo ClinoStar installed base 2026 — error
  • China cell therapy 3D bioprinting regulation 2026 — error
  • Hermes Agent MiniMax M3 changelog 2026 — error
  • OpenWiki connectors Tavily RAGFlow 2026 — error
  • agent personal memory wiki 2026 — error

Synthesis result

  • No new vendor-anchored or application-domain evidence. Backfills the gap between pull 8 and pull 10; pull 7 (2026-07-30) remains the canonical last successful Tavily pull.
  • Coverage: fetched 2026-08-01T18:09:15.810Z; 10 queries (all failed); raw ~/.openwiki/connectors/web-search/raw/2026-08-01T18-07-35-101Z/web-search-results.json; instance web-search-1.

2026-08-02 18:07 pull

Tenth Tavily pull, run as a stand-alone openwiki personal --update source ingest on this connector. All 10 queries returned a structured "error": "fetch failed" — same pattern as pulls 8 (2026-07-31) and 9 (2026-08-01). This makes three consecutive fully-failed Tavily pulls, paralleling the HN connector's third-consecutive-empty-pull streak flagged in /quickstart.md's Current status. No scope or query-phrasing change relative to pulls 1–7, which all produced usable evidence; the failure is Tavily-side / upstream.

Per-query result

Every query in the 10-query lane returned the same structured error (no answer text, no result URLs):

  • CelVivo ClinoReactor spheroid 2026 — error
  • 3Brain CorePlate MEA 2026 — error
  • Cellink BIO X bioprinter 2026 — error
  • organ-on-chip pharma collaboration 2026 — error
  • CellShot CellPick bioprinter 2026 — error
  • labs CelVivo ClinoStar installed base 2026 — error
  • China cell therapy 3D bioprinting regulation 2026 — error
  • Hermes Agent MiniMax M3 changelog 2026 — error
  • OpenWiki connectors Tavily RAGFlow 2026 — error
  • agent personal memory wiki 2026 — error

Synthesis result

  • No new vendor-anchored or application-domain evidence. Pull 7 (2026-07-30) remains the canonical last successful Tavily pull. All theme rows (class-organoid-3d-bioprinting, china-cde-cell-gene-therapy-rules-2026, china-order-no-818-clinical-translation, MiniMax-m3, hermes-agent-v0-19-quicksilver, openwiki-brand, agent-memory-architecture) keep their 2026-07-30 / 2026-07-29 / 2026-07-16 Last seen. No commitments.md and no open-questions.md change.
  • Operational note for the connector. Pull 10 is the third consecutive fully-failed pull (after pulls 8 and 9). The pull 8 note said: "If the next pull also fails, consider checking TAVILY_API_KEY validity, Tavily status page, or rate-limit posture before continuing to schedule the lane." That advice now applies; one fully-failed pull was a probable outage, two was a sustained outage, three is a confirmed Tavily-side outage. Recommend an unscheduled check of TAVILY_API_KEY, Tavily status, and rate-limit posture on disk before scheduling the next scheduled pull. Without that, the Tavily lane should be paused (per the same posture already recommended for the HN lane in /quickstart.md).
  • Coverage: fetched 2026-08-02T18:07:53.246Z; 10 queries (all failed); raw ~/.openwiki/connectors/web-search/raw/2026-08-02T18-06-12-521Z/web-search-results.json; instance web-search-1.

Source coverage (cumulative)

  • Pull 1: fetched 2026-07-26T17:39:11Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T17-38-33-286Z/web-search-results.json
  • Pull 2: fetched 2026-07-26T18:07:27Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T18-07-14-335Z/web-search-results.json
  • Pull 3: fetched 2026-07-26T18:16:21Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-26T18-16-06-804Z/web-search-results.json
  • Pull 4: fetched 2026-07-27T18:04:46Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-27T18-04-01-259Z/web-search-results.json
  • Pull 5: fetched 2026-07-28T18:04:26Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-28T18-03-43-560Z/web-search-results.json
  • Pull 6: fetched 2026-07-29T18:03:26Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-29T18-02-29-119Z/web-search-results.json
  • Pull 7: fetched 2026-07-30T18:04:41Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-30T18-03-34-547Z/web-search-results.json
  • Pull 8: fetched 2026-07-31T18:06:36Z — raw ~/.openwiki/connectors/web-search/raw/2026-07-31T18-04-55-956Z/web-search-results.json — all 10 queries returned "error": "fetch failed"; no usable evidence
  • Pull 9: fetched 2026-08-01T18:09:15Z — raw ~/.openwiki/connectors/web-search/raw/2026-08-01T18-07-35-101Z/web-search-results.json — all 10 queries returned "error": "fetch failed"; no usable evidence (gap-fill, not documented at the time)
  • Pull 10: fetched 2026-08-02T18:07:53Z — raw ~/.openwiki/connectors/web-search/raw/2026-08-02T18-06-12-521Z/web-search-results.json — all 10 queries returned "error": "fetch failed"; no usable evidence
  • Pull 11: fetched 2026-08-03T18:08:50Z — raw ~/.openwiki/connectors/web-search/raw/2026-08-03T18-07-31-803Z/web-search-results.json — first successful pull after the 3-day outage streak; Tavily back online; see section below
  • Pull 12: attempted 2026-08-10T18:35Z — skipped (connector reported disabled; TAVILY_API_KEY not present; no raw files written; no synthesis update)
  • 2026-08-12 / 2026-08-15 / 2026-08-17 / 2026-08-18 / 2026-08-19 / 2026-08-20 / 2026-08-21 / 2026-08-22 update attempts: all skipped on the same code path (connector reported disabled; TAVILY_API_KEY not present; no raw files written; no synthesis update; tenth consecutive skip including 2026-08-22); see individual sections above for per-day operational notes
  • Queries: pulls 1, 2, 4, 5, 6, 7, 8, 9, 10, 11 = 10 queries each; pull 3 = 6 queries (vendor-anchored only)
  • Instance: web-search-1

2026-08-03 18:08 pull

Eleventh Tavily pull, run as a stand-alone openwiki personal --update source ingest after the web-search-1 connector's three-day outage streak (pulls 8/9/10 all returned "error":"fetch failed"). Tavily is back online — all 10 queries returned answer text + 2–8 results per query. The material findings are: the first credible CELLINK × Volumetric "New Lumen X" release signal on the Robin portfolio (Q3, score 0.819, 3DPrint.com 2026-07-28), a new 3Brain Utrecht Summer School "Human Brain Models" course vendor-channel post (Q2, score 0.808, LinkedIn 2026-07-29), an independent CelVivo ClinoStar 2 / Thailand Lab 2026 confirmation from an Indian distributor event page (Q6, score 0.696, labindia-analytical.com 2026-07-31), a Hermes Agent 0.19.1 GitHub bug report (Q8, score 0.790, NousResearch issues/77000, 2026-08-02), and the first pull where Tavily's answer text on 3Brain is correct instead of mis-attributing an EEG-headset paper.

CELLINK × Volumetric release new Lumen X for volumetric bioprinting — source-backed (vendor-anchored, high priority)

Robin relevance: HIGH. Lumen X is in Robin's portfolio table; the CELLINK × Volumetric release is a credible direct product / partnership announcement on a product Robin actively sells. Per the brief's escalation rule ("CelVivo / 3Brain / Cellink / Femtobiomed news item with no prior row in wiki → write to commitments.md with a 1-line 'verify on next vendor check' status"), promoted to a NEW /commitments.md item cellink-volumetric-lumen-x-release. The BioMET '26 + U. Miami items are companion vendor-channel evidence folded into the existing cellink-bio-x-gen3-customer-evidence Notes (no new commitment). The class-organoid-3d-bioprinting theme row gets the Lumen X release added as a third vendor-anchored Cellink signal (alongside the BIO X Gen 3 / BIO X6 customer evidence already in the row).

3Brain Utrecht Summer School Human Brain Models course — source-backed (vendor channel)

  • 3Brain LinkedIn post, 2026-07-29: 3Brain contributes to Utrecht Summer School course on Human Brain Models (score 0.808). Tavily answer text: "The 3Brain CorePlate MEA 2026 is a high-density multi-well electrophysiology platform that supports both focused mechanistic studies and high-throughput screening workflows. It enables scalable, high-resolution electrophysiology for various biological models, including iPSC-derived neuronal or cardi…" — first Tavily pull where the 3Brain answer is not mis-attribution. 3Brain contributing an HD-MEA module to a Utrecht Summer School academic course positions CorePlate for the training / academic-channel segment, complementing the conference-booth evidence (ISSCR / ELRIG) already on the existing 3brain-coreplate-2026-conference-positioning commitment.
  • 3Brain AG company page: 3Brain AG - We empower researchers to explore intelligent biological networks (score 0.839). Vendor corporate page anchoring the same HD-MEA messaging.
  • AIP APL Bioengineering, 2026-07-29: Functional human-derived neurospheroids capture cortical-like network complexity (score 0.339). Application-domain paper on cortical-like networks in human neurospheroids — adjacent evidence for 3Brain-class HD-MEA readouts, not 3Brain-anchored.

Robin relevance: Vendor-channel evidence on the existing 3brain-coreplate-2026-conference-positioning commitment. The Utrecht Summer School post is the academic / training-channel counterpart to the ISSCR / ELRIG conference-booth evidence captured in pull 7. No new commitment; the existing commitment Notes are extended.

CelVivo ClinoStar 2 + Thailand Lab 2026 (independent confirmation) — source-backed

  • labindia-analytical.com News & Events, 2026-07-31: News & Events (score 0.696). Top hit on the labs CelVivo ClinoStar installed base 2026 query. Tavily answer text: "The CelVivo ClinoStar bioreactor is set to be showcased at Thailand Lab 2026, Bangkok, from September 2 to 4, 2026. The ClinoStar 2 model allows precise oxygen regulation and is used in various scient…" (truncated). Independent confirmation of two facts from an Indian distributor event page: (a) CelVivo is exhibiting at Thailand Lab 2026 in Bangkok 2026-09-02 → 2026-09-04, (b) ClinoStar 2 is current product naming with oxygen regulation as a distinguishing feature.
  • The remaining 7 results on this query are Instagram snippets / rotational trophoblast organoids (ScienceDirect S2211124726007151) — same set already documented in pull 7's celvivo-clinostar-2-nams-demo-2026 commitment; no new Instagram evidence to add.

Robin relevance: Independent corroboration of the ClinoStar 2 product naming and the Thailand Lab 2026 booth — directly relevant to the existing celvivo-clinostar-2-nams-demo-2026 verification commitment (the prior pull only had Instagram reels and a NexUs Locus demo snippet as evidence; this is the first non-Instagram, named-event confirmation). No new commitment; the existing commitment Notes are extended.

Hermes Agent 0.19.1 GitHub bug report — source-backed (workflow tooling, low priority)

  • GitHub NousResearch/hermes-agent issues/77000, 2026-08-02: [Bug]: Hermes Agent 0.19.1 gpt-5.6-luna + opencode-go (score 0.790). Confirms a Hermes Agent 0.19.1 patch release landed on the v0.19.x track — a same-week artifact on the Robin daily-driver stack (the prior HN pull on 2026-08-03 surfaced the v0.20.0 release at item 49159200). Tavily answer text for the Hermes/M3 lane is partially fabricated: "release date of June 1, 2026" — Hermes v0.19 Quicksilver is dated 2026-07-25 (per pull 5 evidence), and there is no June 2026 Hermes release in the documented record. Treat the answer text as untrusted; the underlying GitHub issue URL is the credible signal.
  • benchlm.ai, 2026-08-01: DeepSeek V4 Flash vs MiniMax M3: Benchmarks & Cost (score 0.543). Third-party comparison reframing the M3 as "1M context window at $0.30…" — adjacent to MiniMax-m3 theme row.
  • unsloth/MiniMax-M3-GGUF, 2026-08-01: HuggingFace model card (score 0.372). Quantized GGUF artifacts available from unsloth — confirms M3 is on the local-LLM run path. Adjacent to MiniMax-m3 theme row.

Robin relevance: WORKFLOW TOOLING (low priority). Refreshes hermes-agent-v0-19-quicksilver evidence column with the 0.19.1 GitHub bug report and MiniMax-m3 with the benchlm + unsloth artifacts; does not change Last seen (already 2026-08-03 from the HN pull).

Application-domain cross-anchor: 3D bioprinting + microfluidics convergence

Agent-memory-architecture cluster — new corroborating source

  • akitaonrails/ai-memory, GitHub, 2026-07-28: docs/research-karpathy-llm-wiki.md (score 0.601). A third-party research write-up of the Karpathy LLM Wiki pattern — corroborates the agent-memory-architecture theme with another independent GitHub-side implementation / write-up. Combined with the prior 14+ distinct sources, the cluster is now 15+ and remains source-backed.
  • Nvidia RTX Spark debut (tech-insider.org, 2026-07-28): 128 GB Memory, 1 Petaflop AI PC (score 0.558). Adjacent hardware — surfaces on the agent-memory query but is local-LLM inference hardware, not agent-memory architecture per se.

Robin relevance: The akitaonrails write-up is a credible GitHub-side corroboration. Refreshes agent-memory-architecture Last seen → 2026-08-03 and adds to the evidence column.

CellShot / Femtobiomed / OpenWiki-RAGFlow / Tavily answer-text quality

  • CellShot / CellPick: the GEN "Large Bioprinted Tissues Get a Precision Boost" article (already known from pull 6) reappears at 0.056; the asiaresearchnews "Smart bioink shields delicate neural cells during precision bioprinting" (2026-08-03, score 0.368) is a new adjacent application-domain article but has no Femtobiomed attribution; the Pensées cultivated-meat platform at AFPRO (2026-07-28, score 0.154), Oxford Academic rbag142 "Three-dimensional bioprinted organoids: advances" (2026-08-01, score 0.063) are application-domain / market context. No Femtobiomed CellShot / CellPick / TriArm signal was promoted.
  • OpenWiki connectors Tavily RAGFlow 2026: langchain-ai/openwiki GitHub (2026-08-01, score 0.511) reappears as the lone non-noise result; the lane still returns two Instagram reels. Confirms openwiki-brand cluster continuity but does not surface a new openwiki release or a RAGFlow ecosystem shift.
  • Tavily answer-text quality improvement: the 3Brain answer text on Q2 was correct for the first time in this 11-pull series — a positive connector-side signal worth flagging. The Cellink / Lumen X answer text on Q3 was vendor-anchored and substantive. The Hermes Agent / M3 answer text on Q8 was partially fabricated ("release date of June 1, 2026") — treat as untrusted. The CelVivo / ClinoStar installed-base Q6 answer text was correct and substantive (Thailand Lab 2026 + ClinoStar 2).

Synthesis result

  • Three new scope-aligned findings warranting commitment / theme updates:
    1. CELLINK × Volumetric release new Lumen X — first direct Cellink product / partnership release evidence on the Robin portfolio. Promoted to a NEW /commitments.md item cellink-volumetric-lumen-x-release and to the evidence column of class-organoid-3d-bioprinting (third vendor-anchored Cellink signal alongside the existing BIO X Gen 3 / BIO X6 customer evidence).
    2. 3Brain Utrecht Summer School Human Brain Models course — academic / training-channel evidence on the existing 3brain-coreplate-2026-conference-positioning verification commitment. No new commitment; existing commitment Notes are extended.
    3. CelVivo ClinoStar 2 / Thailand Lab 2026 — independent confirmation from an Indian distributor event page on the existing celvivo-clinostar-2-nams-demo-2026 verification commitment. No new commitment; existing commitment Notes are extended.
  • Workflow tooling refreshes: agent-memory-architecture Last seen → 2026-08-03 (akitaonrails/ai-memory research doc added). hermes-agent-v0-19-quicksilver and MiniMax-m3 evidence columns refreshed with same-week artifacts (Last seen unchanged at 2026-08-03 from the HN pull).
  • Tavily answer-text quality: the 3Brain answer is now correct (first time in 11 pulls); the Cellink Lumen X answer is substantive; the Hermes/M3 answer is partially fabricated ("release date of June 1, 2026") — treat as untrusted. Connector-side quality flag for future pulls: continue to treat Tavily answer text as untrusted; trust the underlying URL + score + published_date.
  • Operational note for the connector: Tavily is back online after a 3-day outage streak. The pull 8 / pull 9 / pull 10 advice to check TAVILY_API_KEY, Tavily status, and rate-limit posture no longer applies — the lane is functional again. No connector-side configuration change is required.
  • Coverage: fetched 2026-08-03T18:08:50.866Z; 10 queries; raw ~/.openwiki/connectors/web-search/raw/2026-08-03T18-07-31-803Z/web-search-results.json; instance web-search-1.
Reference in New Issue View Git Blame Copy Permalink